Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
5.04
-0.17 (-3.26%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Neuphoria Therapeutics Employees
As of June 30, 2024, Neuphoria Therapeutics had 24 total employees, including 8 full-time and 16 part-time employees.
Employees
24
Change
n/a
Growth
n/a
Revenue / Employee
$27,613
Profits / Employee
-$342,221
Market Cap
8.86M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 24 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
NEUP News
- 12 days ago - Neuphoria Provides a Review of 2024 and Highlights 2025 Plans - GlobeNewsWire
- 7 weeks ago - Neuphoria Therapeutics to Ring the Nasdaq Opening Bell on March 3rd, 2025 - GlobeNewsWire
- 2 months ago - Neuphoria Therapeutics Inc. to Receive $15M Milestone Payment from Merck - GlobeNewsWire
- 4 months ago - Neuphoria Completes Re-domiciliation and Successor Listing on Nasdaq - GlobeNewsWire